1. 🇮🇳 India Reinstates Export Tax Refund Scheme

From June 1, India has relaunched the RoDTEP (Remission of Duties and Taxes on Exported Products) scheme, offering exporters (including pharma) reimbursements on embedded taxes. This boosts export competitiveness via a transparent, digital claim process reuters.com

2. 📈 Pharma Export Volumes Hit Historic High

India’s pharmaceutical shipments have surged past $30.5 billion in FY 2024‑25—a 9% increase from the previous year—with March alone recording a 31% year-on-year rise to $3.68 billion en.wikipedia.org+2indiashippingnews.com+2newsonair.gov.in

3. 🌍 Africa Continues Strong Pharma Imports

Export of Indian medicines to Africa reached an all-time high of $3.93 billion in 2025, sharply rising from $0.75 billion in 2007—highlighting the region’s growing healthcare demand ippmedia.com.

4. 🏭 Upcoming National Lab Registry

The Indian Ministry of Commerce & Industry is launching a national digital registry for testing laboratories. This platform will speed up sample testing, clearance processes, and online status tracking—minimizing delays and costs economictimes.indiatimes.com.

5. 🇺🇸 U.S. Trade Policy Impacts Pharma

The U.S. is considering imposing new tariffs, including potential duties up to 245% on Chinese APIs and 20% on EU drug imports. In response, global pharma firms are stockpiling shipments into the U.S. ahead of policy shifts economictimes.indiatimes.com+6theguardian.com+6delveinsight.com+6.

🔍 Why It Matters